Longevity’s gone mainstream. So what next?

By now, we all know that longevity has moved into the mainstream, with the lines between ‘healthy ageing’ (i.e. longevity for the masses, circa 2015)  and the science of the Silicon Valley biohackers becoming increasingly blurred. It’s true – longevity doesn’t mean what it once did, but that doesn’t mean we have the answer to what it actually means now. 

There are, of course, still the extremes – the ‘live forever’ narratives and IV longevity treatments with price points attainable for only a select few spring to mind. But there’s also something much more grounded going on. Longevity is increasingly being defined by our healthspan, as well as our lifespan. 

And as it reaches the masses, this is often being interpreted in the most practical terms: can I move well, think clearly and maintain independence as I age?

It might sound subtle, but it’s a shift that’s fundamentally changing how the category is approaching longevity.

The definition problem (again)

As we’ve previously discussed, if we take the broadest possible view, almost every supplement could be positioned through a longevity lens. Omega-3 for joint health? Supporting mobility as you age. Protein? Preserving muscle mass. Fibre? Supporting gut health and metabolic function over time. If we follow this logic, the majority of the supplement and functional food market could be considered longevity products.

But if everything is a longevity product, then the meaning will quickly become lost. And so the challenge for the industry isn’t to claim longevity, but to define it in a way that is meaningful and useful, because without that, we risk turning it into a vague, catch-all narrative that adds little value to either consumers or brands. 

From lifespan to healthspan

If the industry is making longevity more accessible, it’s being driven by a genuine change in consumer mindset. Across multiple countries and age groups, we’re seeing a change in behaviours that align with the idea of extending healthspan, such as a reduction in smoking and drinking and an increase in physical activity levels, especially amongst older adults. 

None of this is framed explicitly as longevity behaviour, but that’s precisely the point. Consumers aren’t waking up and deciding to suddenly pursue longevity; they’re making decisions that help them feel and function better both now and in the future. Longevity, in this sense, is an outcome rather than a goal.

But if consumers are already engaging in longevity-supporting behaviours through diet and lifestyle, where do products genuinely add value?

The science end of the spectrum

Everyday consumers may be the largest audience group, but those at the other end of the spectrum are no less influential and we’re seeing a surge in products grounded in cellular and mitochondrial health, often linked to the hallmarks of ageing. The science is compelling and the message is clear: intervene earlier and act deeper, and you can influence the underlying biology of ageing itself.

But there are a couple of considerations here. 

These products often sit at a significant price premium, which immediately limits their audience, and while terms like mitochondrial health and cellular senescence carry scientific credibility, they remain abstract for most consumers. 

There’s also a more strategic question. These solutions are rightly gaining traction because they represent a genuine advance in how we’re approaching ageing, but as the category matures, will consumers continue to invest in high-cost, mechanism-led interventions, or will we see a rebalancing towards simpler, more familiar approaches?

A return to fundamentals

If we look across the broader nutrition landscape, there is a recurring pattern. New ingredients and science hit the market and gain traction before, in time, making their way into the more accessible products that are used by the masses. 

We’ve already seen this in areas such as gut health, hydration and protein, where the market has shifted from highly specialised propositions towards more accessible, habit-forming solutions. Longevity may follow a similar trajectory.

That’s not to say the science disappears or is redundant – quite the opposite. Interpret longevity how you like, but the solutions targeting cellular and mitochondrial health are genuine game changers. Looking ahead though, the role of science may evolve from being the headline to becoming the foundation that underpins simple, clear consumer propositions. 

Which brings us back to our earlier question: are all products longevity products?

Our answer (after much consideration)? While the majority of products can contribute to longevity in one way or another, not all products are built for it. The distinction lies in intent, positioning and the clarity of the benefit that’s delivered over time.

A reframing 

Longevity may seem new, but really, it’s just a reframing of something we’ve always been interested in: staying well for as long as possible. Call it anti-ageing, call it healthy-ageing, call it agelessness – the terminology may have changed, and the science may have advanced, but the fundamentals remain the same. 

As the category evolves, the winners are unlikely to be those who chase the most extreme interpretation of longevity, but those who can navigate the opportunity in a way that cuts through with consumers, translating a complex, often abstract concept into something that feels relevant, credible and achievable.